Target Name: C2orf78
NCBI ID: G388960
Review Report on C2orf78 Target / Biomarker Content of Review Report on C2orf78 Target / Biomarker
C2orf78
Other Name(s): Chromosome 2 open reading frame 78, transcript variant 1 | chromosome 2 open reading frame 78 | Uncharacterized protein C2orf78 | CB078_HUMAN | hCG1989538 | C2orf78 variant 1 | COG5373

C2orf78: A Potential Drug Target for Telomere Regulation and Cell Signaling

C2orf78, also known as Chromosome 2 open reading frame 78, and transcript variant 1, is a gene that has been identified as a potential drug target or biomarker for various diseases. The gene is located on Chromosome 2 and encodes for a protein known as C2orf78.

C2orf78 is a 21-kDa protein that is expressed in most tissues of the body. The protein is involved in various cellular processes such as cell signaling, DNA replication, and repair. It is also involved in the regulation of cellular processes that are associated with aging, such as the regulation of telomere length.

One of the functions of C2orf78 is its role in regulating telomere length. Telomeres are repetitive DNA sequences at the ends of chromosomes that protect the ends of chromosomes from degradation and fusion. As we age, the telomeres become shortened, leading to the potential for chromosomal instability and the development of age-related diseases.

C2orf78 has been shown to play a role in the regulation of telomere length in various cell types. For example, studies have shown that C2orf78 is highly expressed in human immune cells, such as T cells, and that it is involved in regulating the length of telomeres in these cells. Additionally, C2orf78 has been shown to be involved in the regulation of telomere length in cancer cells.

Another function of C2orf78 is its role in cell signaling. The protein is involved in the regulation of various signaling pathways, including the TGF-β pathway. TGF-β is a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival.

C2orf78 has also been shown to be involved in the regulation of cell signaling in various diseases, including cancer. For example, studies have shown that C2orf78 is involved in the regulation of the PI3K/Akt signaling pathway, which is a pathway that is involved in the regulation of cell signaling. This pathway is often associated with the development of cancer, and C2orf78 has been shown to play a role in its regulation.

In addition to its role in telomere regulation and cell signaling, C2orf78 has also been shown to be involved in the regulation of DNA replication and repair. The protein is involved in the regulation of the Replication-CAP complex, which is a complex that is involved in the regulation of DNA replication.

C2orf78 has also been shown to be involved in the regulation of DNA repair. DNA repair is a critical process that is involved in the regulation of DNA damage and is important for the maintenance of cellular health.

In conclusion, C2orf78 is a gene that has been identified as a potential drug target or biomarker for various diseases. Its functions in telomere regulation, cell signaling, DNA replication, and repair make it an attractive target for therapeutic intervention. Further research is needed to fully understand the role of C2orf78 in disease and to develop effective treatments.

Protein Name: Chromosome 2 Open Reading Frame 78

The "C2orf78 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C2orf78 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C2orf80 | C2orf81 | C2orf83 | C2orf88 | C2orf92 | C3 | C3AR1 | C3orf14 | C3orf18 | C3orf20 | C3orf22 | C3orf33 | C3orf36 | C3orf38 | C3orf49 | C3orf52 | C3orf62 | C3orf70 | C3orf80 | C3orf84 | C3orf85 | C3orf86P | C3P1 | C4A | C4B | C4BPA | C4BPAP2 | C4BPB | C4B_2 | C4orf17 | C4orf19 | C4orf3 | C4orf33 | C4orf36 | C4orf45 | C4orf46 | C4orf46P3 | C4orf47 | C4orf48 | C4orf50 | C4orf51 | C4orf54 | C5 | C5-OT1 | C5AR1 | C5AR2 | C5orf15 | C5orf22 | C5orf24 | C5orf34 | C5orf46 | C5orf47 | C5orf52 | C5orf58 | C5orf60 | C5orf63 | C5orf64 | C5orf64-AS1 | C5orf67 | C6 | C6orf118 | C6orf120 | C6orf132 | C6orf136 | C6orf141 | C6orf15 | C6orf163 | C6orf226 | C6orf47 | C6orf52 | C6orf58 | C6orf62 | C6orf89 | C7 | C7orf13 | C7orf25 | C7orf31 | C7orf33 | C7orf50 | C7orf57 | C8A | C8B | C8G | C8orf33 | C8orf34 | C8orf34-AS1 | C8orf44 | C8orf48 | C8orf58 | C8orf74 | C8orf76 | C8orf82 | C8orf88 | C8orf89 | C9 | C9orf131 | C9orf152 | C9orf153 | C9orf163 | C9orf24